Caption Management, LLC Karyopharm Therapeutics Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $356,000 - $850,400	-80,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $81,100 - $111,100	-10,000 Reduced 11.11%	80,000 $826,000
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $503,300 - $970,200	35,000 Added 63.64%	90,000 $1.73 Million
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $369,200 - $786,800	40,000 Added 266.67%	55,000 $1.05 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $481,100 - $1.01 Million	-85,000 Reduced 85.0%	15,000 $144,000
Q2 2019 Aug 13, 2019	BUY	$4.32 - $6.43 $432,000 - $643,000	100,000 New	100,000 $599,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.